After an initial consult and thorough medical assessment, eligible candidates for Semaglutideand Tirzepatide will receive a prescription. In person instruction on how to self-inject will be taught by a board certified nurse. Throughout the duration of the program, our dedicated nurses will conduct weekly Telehealth check-ins to discuss your weight loss progress, how you are doing and answer any questions you may have.
While self-injecting meds are very common, we understand the anxiety some people might feel. However after the first dosage, most patients report it being painless, quick, and easy.
Your body naturally produces a number of substances that affect your appetite. One of those natural hormones is called glucagon-like peptide 1 (GLP-1). This hormone is produced by the body after eating a meal and targets an area of the brain that regulates blood sugar metabolism, appetite, and food intake. Semaglutide was made to mimic GLP-1. Therefore, when taking Semaglutide you will feel reduced feelings of hunger and you will feel fuller longer, both resulting in reduced food intake and subsequent loss of weight. The FDA approved Semaglutide for weight loss in June of 2021 and since then many patients have used Semaglutide to achieve their weight loss goals.
We welcome patients of all ages who are committed to making positive changes in their lives. However, we recommend that any minors be accompanied by a parent or guardian.
It is important to remember that weight loss takes time and not everyone responds the same way to the medication. Based on our experience, patients can lose up to 25 pounds in 2 months and up to 50 pounds or more in 4 months. On average, patients lose about 15% of their body weight but this can vary depending on the weight of the patient. Patients with more weight to lose can see greater results.
Many patients report an increase in their energy level when there is a decrease in their weight. While exercise is not mandatory to lose weight on the program, we do recommend you start to incorporate an exercise regimen into your lifestyle because of the health benefits.
Any patients with a history of pancreatitis, with a personal or familial history of medullary thyroid cancer, with Type 1 diabetes, with multiple endocrine neoplasia syndrome type 2 (MEN2), with diabetic retinopathy, with decreased kidney function, or who have had a prior allergic reaction to Semaglutide should NOT take Semaglutide.
No, Semaglutide should not be taken by any patients who are pregnant, trying to become pregnant, or breastfeeding.
No, Semaglutide is not a type of insulin or a substitute for insulin.
Semaglutide slows the digestive process and can therefore impact the absorption of oral medications. Make sure to report to your primary care physician that you are on Semaglutide.
While there are no foods that are technically off-limits during the program, refer to the Side Effects and Treatments section of this booklet for a list of foods/drinks we have found are best to limit/avoid. Alcohol and caffeine should be limited or eliminated while on the program as they cause blood sugar levels to fluctuate.
Because Semaglutide slows gastric emptying, the most commonly reported side effects are stomach and gut problems - decreased appetite, nausea, constipation, indigestion/heartburn, diarrhea, and bloating. Dizziness, lethargy, and headaches have also been reported. These side effects are usually mild to moderate and are most likely to happen at the start of your treatment. The side effects are likely to decrease or resolve entirely as you continue through the program. Please refer to the Side Effects treatments section of our booklet for remedies that we have found are best to treat these side effects.